CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
LabKey›
Library
LabKey

LabKey

LabKey develops configurable scientific data management and laboratory software for research organizations.

HQ
Seattle, WA, US
Founded
2003
Loading
Overview
Analysis
Compare
Employees
News
Library

LabKey - Library

Official pages and third-party coverage in one index.

labkey.com·40 items across 34 mapped pages · Crawled Oct 1, 2026·

Topics

Publication type

Content origin
Row density

Official pages and third-party coverage in one index

Product

6 pages
  1. Benefits of Biologics Discovery Software for Hit Selection and Screening/biologics-discovery-software

    Biologics discovery software has numerous benefits for optimizing the efficiency of hit selection and screening. Learn how software can help.

  2. Clinical Sample Management & Compliance in the Lab/clinical-sample-management-compliance

    Clinical trials and sample management require a commitment to maintaining audit-ready and secure files, regardless of the compliance type.

  3. Enhancing Lab Efficiency: Strategies for Clinical Sample Inventory Management/clinical-sample-inventory

    Discover strategies to optimize your lab’s efficiency and effectiveness with the management of clinical sample inventory.

  4. Evaluating an SDMS for Life Science Research/data-management-systems-life-science-research

    Read these tips for selecting an SDMS (scientific data management system) that can meet the requirements of your life science research.

Blog

6 pages
  1. Benefits of Sample-centric Freezer Management Software/benefits-of-sample-centric-freezer-management-software

    Learn how freezer management software can more accurately reflect lab workflows and processes by being sample-centric.

  2. What's New in LabKey 22.3!/whats-new-in-labkey-22-3

    The March 2022 release included changes to LabKey Server SDMS, Sample Manager, and Biologics, as well as two premium resources.

  3. What's New in LabKey 22.7!/whats-new-in-labkey-22-7

    Notes on major July 2022 releases for LabKey's big products of Biologics, Sample Manager, and Server SDMS.

  4. What's New in LabKey 23.3/whats-new-labkey-23-3

    An update on how the three LabKey products have been updated during Q1 of 2023, all to better help science research focus on the science.

Press

6 pages
  1. Clinical Research: Improving Data Management & Reporting with LabKey/isber-2025

    Coming to ISBER 2025? Drop by our booth - map here - to say hi and see Sample Manager and LabKey LIMS in action.

  2. FDA releases COVID MyStudies with support from Harvard Pilgrim Healthcare Institute and LabKey/fda-releases-covid-mystudies-with-support-from-harvard-pilgrim-healthcare-institute-and-labkey

    COVID MyStudies is now available as a free platform to assist investigators in remotely and securely obtaining informed consent from patients

  3. LabKey Kicks Off Abstraction and NLP Pipeline Project for NCI SEER/labkey-kicks-off-abstraction-and-nlp-pipeline-project-for-nci-seer

    LabKey Server SDMS helps kick off NCI SEER Program as a portal for manual annotation and abstraction of key elements.

  4. LabKey Supports for NIAID COVID-19 Immune Response Consortium/labkey-niaid-covid-19-research

    The NIAID Immune Response Consortium developed the HGRepo Informatics Framework in partnership with LabKey to centralize clinical data collected from 14 domestic and international hospital sites.

Careers & Hiring

1 page
  1. Careers/about/careers

    Meaningful and engaging work, valued collaboration, and colleagues who care are big pieces of the equation for working at LabKey.

Pricing

3 pages
  1. Clinical Research: Improving Data Management & Reporting with LabKey/lims-pricing

    Explore the different LIMS pricing models out there, including subscription-based, perpetual licensing, usage-based, and tiered pricing.

  2. License/license

    Your license with LabKey is specified by the specific terms and agreements of your subscription with LabKey Software.

  3. Pricing/pricing

    We believe in transparency, including for our pricing. Take a look to see explore what each LIMS level provides you with.

Comparison

6 pages
  1. CDMS vs EDC: What's Right for Your Clinical Trial?/cdms-vs-edc

    CDMS vs EDC: Both valuable tools for researchers with clinical trials, but deciding which software is best for each trial can be challenging.

  2. Clinical Research: Improving Data Management & Reporting with LabKey/freezerworks-alternative

    Freezerworks alternatives can bring more to your lab. See what choosing the right replacement can mean for your lab's productivity.

  3. Clinical Research: Improving Data Management & Reporting with LabKey/biobank-lims-vs-traditional-lims

    Biobank LIMS are built for long-term specimen management, regulations and research collaboration- which may not be in traditional softwares.

  4. Clinical Research: Improving Data Management & Reporting with LabKey/freezerpro-alternative

    Looking for a FreezerPro alternative means looking at several aspects of sample data management your lab may be handling manually.

About

1 page
  1. About/about

    See why research organizations around the globe love working with LabKey for their scientific data management needs.

Contact

3 pages
  1. Contact Us/about/contact-us

    Contact us to learn more about how our software can bring ease and efficiency to your scientific data management and workflows.

  2. Request Demo/request-demo

    Request a demo of our software tools tailored to your requirements from a LabKey Product Specialist. We're here to help!

  3. Support/support

    Contact us for support. Our customer service team is ready to help bring ease and efficiency to your scientific data management and workflows.

Homepage

1 page
  1. Homepage/

    Trusted by leading scientific labs, LabKey's LIMS, sample management, and lab data management software helps scientific teams move faster.

Privacy

1 page
  1. Privacy/privacy

    Explore LabKey's Privacy Policy, which sets out how we collect, use and protect any information that you provide us.

Not yet classified

1 page
  1. labkey.com/

    Trusted by leading scientific labs, LabKey's LIMS, sample management, and lab data management software helps scientific teams move faster.

Coverage

5 items
  1. LabKey Deploys Biologics LIMS at Valink Therapeutics for Company-Wide R&D Data Infrastructureeinpresswire.com/article/941306303/labkey-deploys-biologics-lims-at-valink-therapeutics-for-company-wide-r-d-data-infrastructure

    LabKey deploys a biologics LIMS at Valink Therapeutics for company-wide R&D data infrastructure. The implementation spans a molecular registry, sample management, assay data capture, and electronic lab notebooks, while Valink builds automation on the LabKey API.

    Sep 2026 · EIN PresswireNews article

  2. LabKey launches new AI capabilities for scientists, grounded in structured, governed lab dataeinpresswire.com/article/930033043/labkey-launches-new-ai-capabilities-for-scientists-grounded-in-structured-governed-lab-data

    LabKey launches LabKey AI, which lets users query lab data in plain language. The capabilities are grounded in structured, governed lab data, with results described as reliable enough for regulated scientific work.

    Jul 2026 · EIN PresswireNews article

  3. LABKEY BIOLOGICS LIMS SUPPORTS HIGH-THROUGHPUT ANTIBODY DEVELOPMENT IN FEDERAL BIODEFENSE RESEARCHeinpresswire.com/article/918523054/labkey-biologics-lims-supports-high-throughput-antibody-development-in-federal-biodefense-research

    LabKey’s Biologics LIMS supports high-throughput antibody development in federal biodefense research. The platform provides structured data management, traceability, and reproducibility for laboratories connecting computational design with physical experimentation.

    Jun 2026 · EIN PresswireNews article

  4. LABKEY LIMS TURNS PROTOCOL STEPS INTO EXECUTABLE WORKFLOW ACTIONS IN THE LABeinpresswire.com/article/907218128/labkey-lims-turns-protocol-steps-into-executable-workflow-actions-in-the-lab

    LabKey LIMS introduces a workflow automation capability that turns protocol steps into executable actions in the lab. It executes sample and data operations in context, eliminating manual handoffs and reducing errors in high-throughput labs.

    Apr 2026 · EIN PresswireNews article